Dreavent Capital
Cambridge, Massachusettsdreavent.com
Overview
Dreavent Capital is a venture capital firm that invests in biotech companies specializing in Oncology, Neurology, Cardiovascular & Metabolic, and Immunology sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| A4Cell | Nov 2023 | Series B | Lead |
| Astrocyte Pharmaceuticals Inc. | Aug 2023 | VC Round | Lead |
| Chimeron Bio | Feb 2022 | Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
